For the Inventor, By the Inventor

Enter assignee name

Budapest, Hungary

Egis Gyogyszergyar Rt.

Calculating rank

USPTO Granted Patents = 33

% Expired Patents = 33.3

EPO Patents = 1

Forward Citations = 79

Loading Chart...

Loading Chart...

229 inventors (with patents filed for the assignee):

Gyula Simig (23 out of 55 patents)

Gabor Blasko (12 out of 19 patents)

Andras Egyed (6 out of 9 patents)

4. Zoltan Budai (6 out of 29 patents)

5. Katalin Szemeredi (6 out of 9 patents)

6. Istvan Gacsalyi (5 out of 20 patents)

7. Gabor Gigler (5 out of 24 patents)

8. József Barkóczy (5 out of 11 patents)

9. Tibor Mezei (5 out of 36 patents)

10. Kalman Nagy (5 out of 13 patents)

11. Istvan Gyertyan (5 out of 24 patents)

12. Gábor Szénási (5 out of 7 patents)

13. Zoltán Greff (4 out of 8 patents)

14. Jozsef Barkoczy (4 out of 20 patents)

15. Imre Klebovich (4 out of 12 patents)

Core Competencies:

Benzodiazepine Derivatives

Pharmaceutical Compositions

Drug Preparation

Pyridazinone Derivatives

Atorvastatin

Anxiolytic Agents

Controlled Drug Release

Heterocyclic Compounds

Amorphous Form

Intermediate Compounds

Ointment Formulations

Skin Irritation

33 patents: Sort by Forward Citations

1. 7960375 - 8-chloro-2,3-benzodiazepine derivatives (2011-06-14),

2. 7396931 - Process for the preparation of amorphous form of a platelet aggregation inhibitor drug (2008-07-08),

3. 7307168 - Process for the preparation of 3-{2-'4- (6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyllethyl}-6,7,8,9-tetrahydro-2-methyl-4h-pyrido′1,2-methyl-4h-pyrido′,2-a!pyrimidin-4-one (2007-12-11),

4. 7189711 - 2, 3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient (2007-03-13),

5. 7186848 - Polymorphs of a 1-pyrrole derivative, intermediate for the preparation of atorvastatin (2007-03-06),

6. 7183283 - Piperidinyl-alkylamino-pyridazinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing said compounds (2007-02-27),

7. 7141604 - Citalopram for the treatment of elevated blood pressure (2006-11-28),

8. 7098210 - 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient (2006-08-29),

9. 7053082 - 2,3-benzodiazepine derivatives (2006-05-30),

10. 6930110 - Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same (2005-08-16),

11. 6908999 - Process for the preparation of {2-[4-α-phenyl-p-chlorobenzyl)piperazin-1-yl]ethoxy} acetic acid and novel intermediates therefor (2005-06-21),

12. 6800758 - Process for the preparation of a 3(2H)-pyridazinone-4- substituted amino 5-chloro derivative (2004-10-05),

13. 6646133 - Process for the preparation of amorphous atorvastatin calcium (2003-11-11),

14. 6562810 - 8-substituted-9H-1,3-dioxolo/4,5-h//2,3/benzodiazepine derivatives, as AMPA/kainate receptor inhibitors (2003-05-13),

15. 6093747 - 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivatives as anxiolytic agents (2000-07-25),

Company Overview

Egis Gyogyszergyar Rt. is a prominent pharmaceutical company based in Budapest, Hungary, specializing in the development and manufacturing of generic and innovative medications. The company focuses on a wide range of therapeutic areas, including cardiovascular, central nervous system, and oncology treatments. With a commitment to research and development, Egis aims to enhance healthcare solutions both locally and internationally, contributing to the advancement of medical science and patient care.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

33 Patents

#7 in Budapest

#7 in Hungary

#20,172 in the World

Budapest, Hungary

Egis Gyogyszergyar Rt.

Forward Citations = 79

229 inventors:

Gyula Simig (23 out of 55 patents)

Gabor Blasko (12 out of 19 patents)

Andras Egyed (6 out of 9 patents)

4. Zoltan Budai (6 out of 29 patents)

5. Katalin Szemeredi (6 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Egis Gyogyszergyar Rt.. Retrieved from https://idiyas.com/company/egis-gyogyszergyar-rt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…